Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)
暂无分享,去创建一个
A. Bennaceur-Griscelli | C. Desterke | A. Turhan | F. Griscelli | Jérôme Artus | I. Sloma | A. Guerci | P. Hugues | A. Foudi | H. Johnson-Ansah | G. Telliam | Lucas E B Souza | Mélanie Gentil | Seda Baykal